Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients

BACKGROUND: Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in HD patients. We examined here the effects of switching from oral administration (PO) to intravenous (IV) injection o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Kidney J
Prif Awduron: Fukami, Kei, Yamagishi, Sho-ichi, Sakai, Kazuko, Nasu, Makoto, Okuda, Seiya
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Original Contributions
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379340/
https://ncbi.nlm.nih.gov/pubmed/25878778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfu082
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg